跳至主要内容
临床试验/ACTRN12610000275066
ACTRN12610000275066招募中未知

Among patients with cervical dystonia, does treating with transcranial magnetic stimulation in addition to botulinum toxin treatment compared with botulinum toxin alone, give additional benefit and improve quality of life

Monash Medical Centre0 个研究点目标入组 32 人开始时间: 2010年4月6日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • Patients are to be recruited from the Botulinum Toxin Outpatient Clinics at the Monash Medical Centre. All consenting patients with clinical diagnosis of rotational cervical dystonia and stable requirements of Botulinum toxin in the previous 6 months will be included

排除标准

  • Exclusion criteria will include those patients with intracranial metal objects or pacemakers, seizures or family history of seizures, pregnant women, those with known excessive alcohol use or serious medical conditions

研究者

发起方
Monash Medical Centre

相似试验